CClinicalTrials.gg
CompletedNCT05233644Updated May 11, 2023

Medication Adherence in Heart Failure After Hospitalisation

An observational study in Adherence, Medication and Heart Failure, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to participants aged 118 Years and older. Per ClinicalTrials.gov, last updated 2023-05-11.

Sponsored by University of Zurich · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
72
Ages
118 Years and older
Sex
All
01

Study summary

To explore medication adherence in patients who were hospitalised due to heart failure.

02

Conditions studied

  • Adherence, Medication
  • Heart Failure

Browse trials for

03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's enrollment of 72 is below the median of 200 across 1,679 observational studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
118 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Heart Failure

Inclusion criteria

  • Diagnosis of Heart failure
  • Hospitalisation due to heart failure in the past two years

Exclusion criteria

Exclusion Criteria:

  • Not speaking German
  • cognitive impairment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
72 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Medication Adherence

    MARS-5 5-Item Medication Adherence Rating Scale

    Time frame: at one timepoint (cross sectional)

07

Study locations

1 site
  • University Hospital Zurich
    Zürich, 8090, Switzerland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05233644
Lead sponsor
University of Zurich
Responsible party
Sponsor
First posted
Feb 10, 2022
Start date
Oct 28, 2021
Primary completion
Oct 30, 2022
Completion
Oct 30, 2022
Last update
May 11, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion